Relationship between serologic profile (ANCA type) and clinical features of renal involvement in ANCA-associated vasculitides

N M Bulanov; E A Makarov; E M Shchegoleva; A S Zykova; E S Vinogradova; P I Novikov; L V Lysenko Kozlovskaya; S V Moiseev

doi:10.26442/terarkh201890615-21

Relationship between serologic profile (ANCA type) and clinical features of renal involvement in ANCA-associated vasculitides

Ter Arkh. 2018 Jun 20;90(6):15-21. doi: 10.26442/terarkh201890615-21.

Authors

N M Bulanov¹, E A Makarov², E M Shchegoleva¹, A S Zykova², E S Vinogradova², P I Novikov¹, L V Lysenko Kozlovskaya¹, S V Moiseev^{1

2}

Affiliations

¹ I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University), Moscow, Russia.
² M.V. Lomonosov Moscow State University, Moscow, Russia.

PMID: 30701899
DOI: 10.26442/terarkh201890615-21

Abstract

Aim: To compare the frequency, clinical features and outcomes of renal involvement in ANCA-associated vasculitides (AAV) in patients with antibodies against proteinase-3 (pr3-ANCA) and myeloperoxidase (MPO-ANCA).

Materials and methods: In our retrospective study we enrolled 264 patients, 94 males and 170 females, median age 53 [36; 62] years. Among them 157 were pr3-ANCA positive and 107 were MPO-ANCA positive. AAV was diagnosed according to ACR criteria and Chapel Hill consensus conference definition (2012). Median follow up was 44 [18; 93] months. We assessed baseline BVAS and VDI by the end of the follow up. Serum creatinine (sCr), estimated glomerular filtration rate (eGFR), hematuria and daily proteinuria were estimated. Diagnosis and stage of chronic kidney disease (CKD) and acute kidney injury (AKI) were established according to KDIGO guidelines (2012) and Scientific Society of Russian Nephrologists (2016).

Results: Renal involvement was present in 181 (68.6%) patients, and its frequency was similar in pr3-ANCA and MPO-ANCA subgroups. Patients with MPO-ANCA developed rapidly progressive glomerulonephritis and hypertension significantly more often than patients with pr3-ANCA: 50.7% vs 35.6% (p=0.049) and 46.1% vs 29.8% (p=0.029) respectively. At disease onset, median sCr was significantly higher and eGFR was significantly lower in patients with MPO-ANCA (p<0.05). 1-year and 5-year renal survival rates were similar in pr3-ANCA-positive (93.9% and 87.4% respectively) and MPO-ANCA positive patients (87.4% and 83.1% respectively). Median BVAS and VDI scores were significantly higher in pr3-ANCA subgroup. The number of patients who developed AAV relapse during 1-year follow up was also significantly higher in pr3-ANCA subgroup. The frequency of eye and ENT involvement was significantly higher in pr3-ANCA positive patients than in MPO-ANCA-positive patients.

Conclusion: The frequency of extrarenal manifestations, clinical features of renal involvement and relapse rate are associated with AAV serotype.

Keywords: ANCA-associated vasculitis; glomerulonephritis; myeloperoxidase; proteinase-3.

MeSH terms

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis* / complications
Antibodies, Antineutrophil Cytoplasmic*
Female
Humans
Kidney Diseases* / etiology
Male
Middle Aged
Myeloblastin
Retrospective Studies
Russia

Substances

Antibodies, Antineutrophil Cytoplasmic
Myeloblastin